Supernus Pharmaceuticals (SUPN) Current Deferred Revenue (2011 - 2017)
Supernus Pharmaceuticals (SUPN) posted quarterly Current Deferred Revenue of $287000.0 for Q4 2017, down 77.92% on a QoQ basis from $1.3 million in Q3 2015.
Supernus Pharmaceuticals (SUPN) Current Deferred Revenue (2011 - 2017) Analysis & Trends
Supernus Pharmaceuticals has reported Current Deferred Revenue for 6 years, with the latest figure at $287000.0 in Q4 2017.
- Current Deferred Revenue for Q4 2017 came in at $287000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $287000.0 (changed N/A YoY), and the FY2017 annual result was $287000.0, changed N/A from the prior year.
- Current Deferred Revenue retreated to $287000.0 in Q4 2017, from $1.3 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.6 million in Q4 2013 and troughed at $287000.0 in Q4 2017.
- A 4-year average of $1.2 million and a median of $1.3 million in 2015 frame the typical range for Current Deferred Revenue.
- The widest annual swing landed in 2013, when Current Deferred Revenue surged 214.96%; it then retreated 12.5% in 2014.
- A 4-year view of Current Deferred Revenue shows it stood at $1.6 million in 2013, then retreated by 12.5% to $1.4 million in 2014, then retreated by 7.14% to $1.3 million in 2015, then plunged by 77.92% to $287000.0 in 2017.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $287000.0 in Q4 2017, $1.3 million in Q3 2015, and $1.3 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.37 Bn | 185.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 287,000.00 |
| Sep 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 100,000.00 |
| Dec 31, 2014 | 1.40 Mn |
| Dec 31, 2013 | 1.60 Mn |
| Dec 31, 2012 | 508,000.00 |
| Sep 30, 2012 | 576,000.00 |
| Jun 30, 2012 | 365,000.00 |
| Mar 31, 2012 | 232,000.00 |
| Dec 31, 2011 | 232,000.00 |